Funding profile · Digital health infrastructure
Junction
Two announced rounds totalling $20.9 million, no Form D anywhere in EDGAR, and a UK company still carrying one pound of share capital. The capital picture has to be read off British filings and press releases, not American ones.
$18.0MSeries A led by Creandum, announced Mar 11, 2025
$2.9MSeed led by Point Nine, announced Jun 24, 2022
$20.9MTotal disclosed across both rounds
0Form D notices filed with the SEC
Data as of September 24, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Winter 2020 | Y Combinator batch, per the YC directory | Not disclosed | Y Combinator | YC listing |
| Nov 5, 2021 | UK incorporation, ADEPT LABS LIMITED | GBP 1 of share capital | Maitham Assaad Dib, sole director and sole controller | Companies House |
| Jun 24, 2022 | Seed | $2.9M | Led by Point Nine; 20VC, Amino Collective, Adventure Fund, Inflect Health; angels including Johannes Schildt (Kry), Kristian Ranta (Meru Health), Jesse Dhillon (Plaid) | Company post |
| Mar 11, 2025 | Series A, announced with the rename from Vital | $18.0M | Led by Creandum (Sabina Wizander); Y Combinator, Point Nine, Amino Collective, Inflect Health | Reported and company |
| To date | Regulation D offerings | None recorded | Not applicable | No filing |
What the filings show
ADEPT LABS LIMITED · Companies House · incorporated Nov 5, 2021
- Company number
- 13725704
- Registered office
- 483 Green Lanes, London, England, N13 4BS
- Capital
- GBP 1 at incorporation. No return of allotment filed since.
- Officers
- 1 director, 0 resignations
- Director
- Maitham Assaad Dib, born Aug 1993, British, appointed Nov 5, 2021
- Control
- 1 person with significant control: Maitham Assaad Dib, significant influence or control
- Accounts
- Micro entity accounts for year ends Nov 2022, 2023, 2024 and 2025
- Business
- SIC 62012, business and domestic software development
Adept Labs Inc. dba Junction · SEC EDGAR · no filings found
- Company search
- No matching companies for Adept Labs
- Full text search
- 0 hits for the phrase Adept Labs, across all form types
- Form D
- 0 notices
- Checked
- Sep 24, 2026
- Not this company
- Junction Health, Inc., CIK 0002031239, of Denver, filed Form D on Jul 23, 2024 and an amendment on May 22, 2026, reporting $8,250,000 offered and $3,125,000 sold from 5 investors. No officer, address or year matches.
Reading the filings
- The money was announced but never filed.$20.9 million across two rounds, and nothing in EDGAR. A US issuer selling under Regulation D must file a Form D within 15 days of the first sale. An issuer relying on Section 4(a)(2), or selling offshore under Regulation S, files nothing. Junction began as a London company raising from European funds, so the gap is explainable. It also leaves no filed figure to test the press releases against.
- Do not read the Denver company as this one.EDGAR holds Form D notices from a Junction Health, Inc. in Colorado, incorporated in Delaware in 2024, with five officers and $3,125,000 sold. None of it connects. Anyone pulling Junction’s funding history from an EDGAR name search picks up the wrong issuer.
- The UK entity never received the capital.Adept Labs Limited was incorporated with GBP 1 of share capital and has filed no return of allotment in almost five years. It has filed micro entity accounts for every year end from Nov 2022 to Nov 2025, a regime open only to very small companies. An $18 million Series A did not land here. The operating parent is the US company, Adept Labs Inc., which the terms of service name as the contracting entity under Delaware law.
- One name still holds the British company.Maitham Assaad Dib has been sole director since incorporation and is the only person with significant control. Two rounds on, Companies House shows no investor director and no second officer.
- With no filings, the commercial record carries the weight.There is no FDA clearance, no registered trial and no federal grant. What can be checked is the customer list: TechCrunch named Found, Parsley Health and Evidation, and Longevity.Technology named Lifeforce. Junction claims more than 140 organisations. Revenue is undisclosed; GetLatka estimates $4.1 million for 2024, an outside estimate rather than a company figure.
- Two volume numbers landed on the same day.On March 11, 2025 the company release and Longevity.Technology both reported more than 500,000 lab tests a year, while Dib told TechCrunch the company was “on track to do about a million lab tests this year.” Neither figure has an audited source.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Regulatory | Junction is not the testing laboratory and holds no FDA record. It works only with CLIA and CAP certified labs, and those certificates sit with Labcorp, Quest and BioReference Health. | Company-stated |
| Ordering | A physician network covering all 50 states supplies the doctor’s order. No consults and no result interpretation. The physician group is not named publicly. | Company-stated |
| Coverage | All 50 states. New York and New Jersey opened in Oct 2024 through BioReference, with 77 patient service centres and no third party insurance. | Company-stated |
| Security | SOC 2 Type 2 and ISO 27001 claimed, with GDPR Ready and HIPAA Compliant badges. Signed BAA and the reports are Enterprise features. No HITRUST found. | Company-stated |
| Customers | Found, Parsley Health, Evidation and Lifeforce named by third parties; Wyndly and Avon Health by the company. More than 140 claimed. | Independent and company |
| Pricing | Launch plan $300 a month for up to 500 connected users. Lab testing sits in Enterprise only, minimum order 250 kits, no upcharge on tests. | Company-stated |
What to watch
- A Form D, if the next round is sold into the United States under Regulation D.
- A return of allotment at Companies House, showing the UK entity capitalised.
- A second officer or an investor director appearing on the UK register.
- Any audited or repeated lab volume figure, after two were published on one day.
- Whether the device count settles. The site said 500 or more in March 2025, and 300 or more now.
The Junction story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordADEPT LABS LIMITED 13725704: overview, officers, PSC, filing history
- Public recordEDGAR company and full text searches for Adept Labs, no filings
- Public recordForm D and Form D/A of Junction Health, Inc., CIK 0002031239, a separate company
- IndependentJunction, an API to link health wearables with labs, raises $18M
- IndependentJunction lands $18m for decentralized healthcare
- EstimateJunction revenue and headcount estimates
- DirectoryJunction company listing, batch and founding year
- CompanyMeet Junction: $18M to Power Personalized Care
- CompanyAnnouncing our $2.9m seed round led by Point Nine
- CompanyTerms of Service naming Adept Labs Inc. dba Junction
- CompanyPricing page and FAQ, lab certification and doctor’s order statements
Compiled from Companies House, SEC and other public records and published reports as of September 24, 2026. No Form D notice has been filed for this company; amounts shown are as announced by the company or reported by the press. Healthcare Venture Capital Fund holds no position in Junction. This page is not an offer to sell or a recommendation to buy any security.